Gilead 支持的 Aspen Neuroscience IPO 后股价下跌 0.7%

Gilead-Backed Aspen Neuroscience Shares Dip 0.7% After IPO

AI 导读

Gilead Sciences 支持的临床阶段细胞疗法开发商 Aspen Neuroscience 完成约 1.406 亿美元 IPO 后，股价下跌。公司以每股 15 美元发行约 940 万股，首日开盘价为 14.70 美元，低于发行价。

正文

Health

Pedestrians near the New York Stock Exchange.

Photographer: Michael Nagle/Bloomberg

October 30, 2026 at 3:53 PM UTC

Takeaways by Bloomberg AI

Aspen Neuroscience Inc., a clinical-stage developer of cell therapies, fell 2% after raising about $140.6 million in a US initial public offering.

Shares of the company, which counts Gilead Sciences Inc. as a backer, opened at $14.70 each in New York, below the IPO price of $15. Aspen sold about 9.4 million shares and offered them for $15 to $17 each, according to its filings with the US Securities and Exchange Commission.

来源：Bloomberg Markets · bloomberg.com